World Health Organization. Global tuberculosis report 2021. 2021. https://www.who.int/publications/i/item/9789240037021. Accessed 1 Nov 2021.
Creswell J, Sahu S, Sachdeva KS, Ditiu L, Barreira D, Mariandyshev A, Mingting C, Pillay Y. Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda. Bull World Health Organ. 2014;92(6):459–60.
Article
PubMed
PubMed Central
Google Scholar
World Health Organization. Global tuberculosis report 2020. 2020. https://www.who.int/publications/i/item/9789240013131. Accessed 1 Nov 2021.
World Health Organization. The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015. 2014. https://www.who.int/tb/strategy/End_TB_Strategy.pdf. Accessed 4 July 2021.
Floyd K, Glaziou P, Houben R, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016–2035: definition and rationale. Int J Tuberc Lung Dis. 2018;22(7):723–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
United Nations General Assembly. A/RES/73/3. Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis. 2018. https://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/73/3. Accessed 4 July 2021.
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. 2020. https://www.who.int/publications/i/item/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment. Accessed 4 July 2020.
Shete PB, Reid M, Goosby E. Message to world leaders: we cannot end tuberculosis without addressing the social and economic burden of the disease. Lancet Glob Health. 2018;6(12):e1272–3.
Article
PubMed
Google Scholar
Hoos A, Anderson J, Boutin M, Dewulf L, Geissler J, Johnston G, Joos A, Metcalf M, Regnante J, Sargeant I, et al. Partnering with patients in the development and lifecycle of medicines: A call for action. Ther Innov Regul Sci. 2015;49(6):929–39.
Article
PubMed
PubMed Central
Google Scholar
Reichler MR, Khan A, Yuan Y, Chen B, McAuley J, Mangura B, Sterling TR. Tuberculosis epidemiologic studies consortium task order team: Duration of exposure among close contacts of patients with infectious tuberculosis and risk of latent tuberculosis infection. Clin Infect Dis. 2020;71(7):1627–34.
Article
PubMed
Google Scholar
World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017. https://apps.who.int/iris/bitstream/handle/10665/255052/9789241550000-eng.pdf. Accessed 4 July 2021.
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. 2020. https://www.who.int/publications/i/item/9789240007048. Accessed 4 July 2021.
Hoger S, Lykens K, Beavers SF, Katz D, Miller TL. Longevity loss among cured tuberculosis patients and the potential value of prevention. Int J Tuberc Lung Dis. 2014;18(11):1347–52.
Article
CAS
PubMed
Google Scholar
Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-tuberculosis lung disease: Clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751–63.
Article
PubMed
Google Scholar
Mkoko P, Naidoo S, Mbanga LC, Nomvete F, Muloiwa R, Dlamini S. Chronic lung disease and a history of tuberculosis (post-tuberculosis lung disease): Clinical features and in-hospital outcomes in a resource-limited setting with a high HIV burden. S Afr Med J. 2019;109(3):169–73.
Article
CAS
PubMed
Google Scholar
Matakanye H, Ramathuba DU, Tugli AK. Caring for tuberculosis patients: Understanding the plight of nurses at a regional hospital in Limpopo Province, South Africa. Int J Environ Res Public Health. 2019;16(24):4977.
Article
PubMed Central
Google Scholar
Thomas BE, Kumar JV, Periyasamy M, Khandewale AS, Hephzibah Mercy J, Raj EM, Kokila S, Walgude AS, Gaurkhede GR, Kumbhar JD, et al. Acceptability of the medication event reminder monitor for promoting adherence to multidrug-resistant tuberculosis therapy in two Indian cities: Qualitative study of patients and health care providers. J Med Internet Res. 2021;23(6): e23294.
Article
PubMed
PubMed Central
Google Scholar
Milligan H, Iribarren SJ, Chirico C, Telles H, Schnall R. Insights from participant engagement with the tuberculosis treatment support tools intervention: Thematic analysis of interactive messages to guide refinement to better meet end user needs. Int J Med Inform. 2021;149: 104421.
Article
PubMed
Google Scholar
Dias AA, de Oliveira DM, Turato ER, de Figueiredo RM. Life experiences of patients who have completed tuberculosis treatment: a qualitative investigation in southeast Brazil. BMC Public Health. 2013;13:595.
Article
PubMed
PubMed Central
Google Scholar
Bhattacharya Chakravarty A, Rangan S, Dholakia Y, Rai S, Kamble S, Raste T, Shah S, Shah S, Mistry N. Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us. PLoS ONE. 2019;14(1): e0209924.
Article
CAS
PubMed
PubMed Central
Google Scholar
Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125(Suppl 4):34–42.
Article
PubMed
PubMed Central
Google Scholar
The European Parliament and the Council of the European Union: Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). Official Journal of the European Union. 2016;L119:1-88.
An Q, Song W, Liu J, Tao N, Liu Y, Zhang Q, Xu T, Li S, Liu S, Li Y, et al. Primary drug-resistance pattern and trend in elderly tuberculosis patients in Shandong, China, from 2004 to 2019. Infect Drug Resist. 2020;13:4133–45.
Article
PubMed
PubMed Central
Google Scholar
Isman E, Ekeus C, Berggren V. Perceptions and experiences of female genital mutilation after immigration to Sweden: an explorative study. Sex Reprod Healthc. 2013;4(3):93–8.
Article
PubMed
Google Scholar
Isman E, Mahmoud Warsame A, Johansson A, Fried S, Berggren V. Midwives’ experiences in providing care and counselling to women with female genital mutilation (FGM) related problems. Obstet Gynecol Int. 2013;2013:785148.
Article
PubMed
PubMed Central
Google Scholar
Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18:59–82.
Article
Google Scholar
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
Article
Google Scholar
Green J, Thorogood N. Qualitative methods for health research. 2nd ed. London: Sage; 2009.
Google Scholar
Aragao FBA, Arcencio RA, Fuentealba-Torres M, Carneiro TSG, Souza LLL, Alves YM, Fiorati RC. Impact of social protection programs on adults diagnosed with tuberculosis: systematic review. Rev Bras Enferm. 2021;74(3): e20190906.
Article
PubMed
Google Scholar
Sinha P, Carwile M, Bhargava A, Cintron C, Acuna-Villaorduna C, Lakshminarayan S, Liu AF, Kulatilaka N, Locks L, Hochberg NS. How much do Indians pay for tuberculosis treatment? A cost analysis. Public Health Action. 2020;10(3):110–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu CH, Jeyashree K, Shewade HD, Xia YY, Wang LX, Liu Y, Zhang H, Wang L. Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty. 2019;8(1):46.
Article
PubMed
PubMed Central
Google Scholar
Stracker N, Hanrahan C, Mmolawa L, Nonyane B, Tampi R, Tucker A, West N, Lebina L, Martinson N, Dowdy D. Risk factors for catastrophic costs associated with tuberculosis in rural South Africa. Int J Tuberc Lung Dis. 2019;23(6):756–63.
Article
CAS
PubMed
Google Scholar
Yang T, Chen T, Che Y, Chen Q, Bo D. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China. BMC Public Health. 2020;20(1):1009.
Article
PubMed
PubMed Central
Google Scholar
Lu L, Jiang Q, Hong J, Jin X, Gao Q, Bang H, DeRiemer K, Yang C. Catastrophic costs of tuberculosis care in a population with internal migrants in China. BMC Health Serv Res. 2020;20(1):832.
Article
PubMed
PubMed Central
Google Scholar
Moreira A, Kritski AL, Carvalho ACC. Social determinants of health and catastrophic costs associated with the diagnosis and treatment of tuberculosis. J Bras Pneumol. 2020;46(5):e20200015.
Article
PubMed
Google Scholar
Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health. 2017;17(1):221.
Article
CAS
PubMed
PubMed Central
Google Scholar
Patel BH, Jeyashree K, Chinnakali P, Vijayageetha M, Mehta KG, Modi B, Chavda PD, Dave PV, Zala CC, Shewade HD, et al. Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study. BMJ Open. 2019;9(12):e033158.
Article
PubMed
PubMed Central
Google Scholar
Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lonnroth K, Barreira D, Boccia D. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study. PLoS Med. 2017;14(11):e1002418.
Article
PubMed
PubMed Central
Google Scholar
Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben R, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Health. 2017;5(11):e1123–32.
Article
PubMed
PubMed Central
Google Scholar
Lu SH, Tian BC, Kang XP, Zhang W, Meng XP, Zhang JB, Lo SK. Public awareness of tuberculosis in China: a national survey of 69 253 subjects. Int J Tuberc Lung Dis. 2009;13(12):1493–9.
PubMed
Google Scholar
Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas AN, Kumar AMV, Parmar M. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tuberc. 2018;65(1):41–7.
Article
CAS
PubMed
Google Scholar
Zvonareva O, van Bergen W, Kabanets N, Alliluyev A, Filinyuk O. Experiencing syndemic: Disentangling the biosocial complexity of tuberculosis through qualitative research. J Biosoc Sci. 2019;51(3):403–17.
Article
PubMed
Google Scholar
Chen X, Wu R, Xu J, Wang J, Gao M, Chen Y, Pan Y, Ji H, Duan Y, Sun M, et al. Prevalence and associated factors of psychological distress in tuberculosis patients in Northeast China: a cross-sectional study. BMC Infect Dis. 2021;21(1):563.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee LY, Tung HH, Chen SC, Fu CH. Perceived stigma and depression in initially diagnosed pulmonary tuberculosis patients. J Clin Nurs. 2017;26(23–24):4813–21.
Article
PubMed
Google Scholar
Qiu L, Tong Y, Lu Z, Gong Y, Yin X. Depressive symptoms mediate the associations of stigma with medication adherence and quality of life in tuberculosis patients in China. Am J Trop Med Hyg. 2019;100(1):31–6.
Article
PubMed
Google Scholar
Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y, Zhu X, Zhou L. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC Public Health. 2021;21(1):6.
Article
PubMed
PubMed Central
Google Scholar
Sathar F, Velen K, Peterson M, Charalambous S, Chetty-Makkan CM. “Knock”: a qualitative study exploring the experience of household contacts on home visits and their attitude towards people living with TB in South Africa. BMC Public Health. 2020;20(1):1047.
Article
PubMed
PubMed Central
Google Scholar
Rajalakshmi M, Kalaiselvan G, Sudhakar R, Dhikale PT. An exploratory mixed method study on the follow up status and quality of life among recurrent tuberculosis patients in South India. Indian J Tuberc. 2020;67(4):515–22.
Article
CAS
PubMed
Google Scholar
Ngamvithayapong J, Winkvist A, Diwan V. High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area. Thailand AIDS. 2000;14(10):1413–9.
Article
CAS
PubMed
Google Scholar
Lince-Deroche N, Leuner R, Kgowedi S, Moolla A, Madlala S, Manganye P, Xhosa B, Govathson C, White Ndwanya T, Long L. Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa. PLoS ONE. 2020;15(10):e0230849.
Article
CAS
PubMed
PubMed Central
Google Scholar
Daftary A, Mondal S, Zelnick J, Friedland G, Seepamore B, Boodhram R, Amico KR, Padayatchi N, O’Donnell MR. Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. Lancet Glob Health. 2021;9(4):e479–88.
Article
PubMed
PubMed Central
Google Scholar
Daftary A, Padayatchi N, O’Donnell M. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa. Glob Public Health. 2014;9(9):1107–16.
Article
PubMed
PubMed Central
Google Scholar
Daniels J, Medina-Marino A, Glockner K, Grew E, Ngcelwane N, Kipp A. Masculinity, resources, and retention in care: South African men’s behaviors and experiences while engaged in TB care and treatment. Soc Sci Med. 2021;270: 113639.
Article
PubMed
PubMed Central
Google Scholar
da Silva RD, de Luna FDT, de Araujo AJ, Camelo ELS, Bertolozzi MR, Hino P, Lacerda SNB, Fook SML, de Figueiredo T. Patients’ perception regarding the influence of individual and social vulnerabilities on the adherence to tuberculosis treatment: a qualitative study. BMC Public Health. 2017;17(1):725.
Article
PubMed
PubMed Central
Google Scholar
Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Alvarez-Navascues F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020. Emerg Infect Dis. 2020;26(11):2709–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Santos FLD, Souza LLL, Bruce ATI, Crispim JA, Arroyo LH, Ramos ACV, Berra TZ, Alves YM, Scholze AR, Costa F, et al. Patients’ perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study. PLoS ONE. 2021;16(4):e0249822.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond). 2020;52(12):902–7.
Article
Google Scholar
Maciel ELN, Goncalves Junior E, Dalcolmo MMP. Tuberculosis and coronavirus: what do we know? Epidemiol Serv Saude. 2020;29(2):e2020128.
PubMed
Google Scholar
Singh A, Prasad R, Gupta A, Das K, Gupta N. Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal. Monaldi Arch Chest Dis. 2020;90(3):441–50.
Article
Google Scholar
European Pharmaceutical Market Research Association. Code of Conduct 2020. 2020. https://www.ephmra.org/media/4857/ephmra-2020-code-of-conduct-final.pdf. Accessed 8 Feb 2022.
International Chamber of Commerce, European Society for Opinion and Marketing Research. ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics. 2016. https://esomar.org/code-and-guidelines/icc-esomar-code. Accessed 8 February 2022.
British Healthcare Business Intelligence Association. Legal and Ethical Guidelines for Healthcare Market Research: Your essential guide. 2021. https://www.bhbia.org.uk/guidelines-and-legislation/legal-and-ethical-guidelines. Accessed 8 Feb 2022.